2024-2028年全球免疫沉淀分析法市场

免疫沉淀分析法市场预计在 2023-2028 年期间成长 2.701 亿美元，预测期内复合年增长率为 6.01%。

该报告包括对免疫沉淀分析法市场的总体分析、市场规模和预测、趋势、成长驱动因素、挑战以及涵盖约 25 家供应商的供应商分析。

它提供了对当前市场状况、最新趋势和驱动因素以及整体市场环境的最新分析。该市场的推动因素包括生物製药研究和开发的增加、对治疗性抗体的需求不断增长以及对新生儿筛检测试的日益关注。

研究认为，基因组计划的兴起将成为未来几年推动免疫沉淀分析法市场成长的关键因素之一。此外，临床试验的增加以及受託製造厂商和研究组织的扩张将带来巨大的市场需求。

目录

第一章执行摘要

• 市场概况

第二章 市场状况

• 市场生态系统

第三章 市场规模评估

• 市场定义
• 细分市场分析
• 2023 年市场规模
• 2023-2028年市场展望

第四章 市场规模表现

• 2018-2022年全球免疫沉淀分析法市场
• 2018-2022 年最终用户細項分析
• 2018-2022 年按类型分類的细分市场分析
• 2018-2022 年区域細項分析
• 2018-2022 年国家細項分析

第五章五力分析

• 五力摘要
• 买方议价能力
• 供应商的议价能力
• 新进入者的威胁
• 替代品的威胁
• 竞争威胁
• 市场状况

第 6 章市场区隔：按最终用户

• 细分市场
• 比较：按最终用户
• 学术研究院：2023-2028年市场规模及预测
• 合约研究机构：2023-2028年市场规模及预测
• 製药和生物技术公司：2023-2028 年市场规模和预测
• 市场机会：依最终用户划分

第七章市场区隔：依类型

• 细分市场
• 比较：按类型
• 染色质免疫沉淀分析法：2023-2028年市场规模及预测
• 个体蛋白质免疫沉淀分析法：2023-2028 年市场规模与预测
• 免疫共沉淀法：2023-2028年市场规模及预测
• RNA免疫沉淀分析法：2023-2028年市场规模与预测
• 市场机会：按类型

第八章 客户状况

• 客户状况概览

第九章 地区情势

• 区域细分
• 区域比较
• 北美：2023-2028 年市场规模与预测
• 欧洲：2023-2028 年市场规模与预测
• 亚洲：2023-2028年市场规模与预测
• 世界其他地区：2023-2028 年市场规模与预测
• 美国：2023-2028 年市场规模与预测
• 英国：2023-2028 年市场规模与预测
• 中国：2023-2028年市场规模及预测
• 德国：2023-2028 年市场规模与预测
• 加拿大：2023-2028 年市场规模与预测
• 市场机会：依地区状况

第 10 章 驱动因素、挑战与趋势

• 市场驱动因素
• 市场挑战
• 驱动因素和挑战的影响
• 市场趋势

第十一章 供应商情况

• 概述
• 供应商情况
• 混乱的情况
• 产业风险

第十二章供应商分析

• 交易厂商
• 供应商市场定位
• Active Motif Inc.
• Agilent Technologies Inc.
• Becton Dickinson and Company
• Bio Rad Laboratories Inc.
• Cell Signaling Technology Inc.
• Danaher Corp.
• GenScript Biotech Corp.
• JSR Micro Inc.
• Merck KGaA
• OriGene Technologies Inc.
• PerkinElmer Inc
• Proteintech Group Inc.
• Rockland Immunochemicals Inc.
• Santa Cruz Biotechnology Inc.
• Thermo Fisher Scientific Inc.

第十三章附录

The immunoprecipitation market is forecasted to grow by USD 270.1 mn during 2023-2028, accelerating at a CAGR of 6.01% during the forecast period. The report on the immunoprecipitation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing r and d in biopharmaceuticals, rising demand for therapeutic antibodies, and growing focus on newborn screening tests.

Technavio's immunoprecipitation market is segmented as below:

By End-user

• Academic and research institutes
• Contract research organizations
• Pharmaceutical and biotechnology companies

By Type

• Chromatin immunoprecipitation
• Individual protein immunoprecipitation
• Co-immunoprecipitation
• RNA immunoprecipitation

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the rising number of genome projects as one of the prime reasons driving the immunoprecipitation market growth during the next few years. Also, increasing clinical trials and growing expansion of contract manufacturing organizations and cros will lead to sizable demand in the market.

The report on the immunoprecipitation market covers the following areas:

• Immunoprecipitation market sizing
• Immunoprecipitation market forecast
• Immunoprecipitation market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading immunoprecipitation market vendors that include Active Motif Inc., Agilent Technologies Inc., Becton Dickinson and Company, Bio Rad Laboratories Inc., Cell Signaling Technology Inc., Chargen Life Sciences LLP, CLOUD CLONE CORP., Creative Biolabs, Danaher Corp., GenScript Biotech Corp., JSR Micro Inc., Merck KGaA, OriGene Technologies Inc., PerkinElmer Inc, Proteintech Group Inc., Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Sino Biological Inc., and Thermo Fisher Scientific Inc.. Also, the immunoprecipitation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview

2 Market Landscape

• 2.1 Market ecosystem

3 Market Sizing

• 3.1 Market definition
• 3.2 Market segment analysis
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

• 4.1 Global immunoprecipitation market 2018 - 2022
• 4.2 End-User Segment Analysis 2018 - 2022
• 4.3 Type Segment Analysis 2018 - 2022
• 4.4 Geography Segment Analysis 2018 - 2022
• 4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

• 5.1 Five forces summary
• 5.2 Bargaining power of buyers
• 5.3 Bargaining power of suppliers
• 5.4 Threat of new entrants
• 5.5 Threat of substitutes
• 5.6 Threat of rivalry
• 5.7 Market condition

6 Market Segmentation by End-user

• 6.1 Market segments
• 6.2 Comparison by End-user
• 6.3 Academic and research institutes - Market size and forecast 2023-2028
• 6.4 Contract research organizations - Market size and forecast 2023-2028
• 6.5 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
• 6.6 Market opportunity by End-user

7 Market Segmentation by Type

• 7.1 Market segments
• 7.2 Comparison by Type
• 7.3 Chromatin immunoprecipitation - Market size and forecast 2023-2028
• 7.4 Individual protein immunoprecipitation - Market size and forecast 2023-2028
• 7.5 Co-immunoprecipitation - Market size and forecast 2023-2028
• 7.6 RNA immunoprecipitation - Market size and forecast 2023-2028
• 7.7 Market opportunity by Type

8 Customer Landscape

• 8.1 Customer landscape overview

9 Geographic Landscape

• 9.1 Geographic segmentation
• 9.2 Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• 9.4 Europe - Market size and forecast 2023-2028
• 9.5 Asia - Market size and forecast 2023-2028
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• 9.7 US - Market size and forecast 2023-2028
• 9.8 UK - Market size and forecast 2023-2028
• 9.9 China - Market size and forecast 2023-2028
• 9.10 Germany - Market size and forecast 2023-2028
• 9.11 Canada - Market size and forecast 2023-2028
• 9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• 11.3 Landscape disruption
• 11.4 Industry risks

12 Vendor Analysis

• 12.1 Vendors covered
• 12.2 Market positioning of vendors
• 12.3 Active Motif Inc.
• 12.4 Agilent Technologies Inc.
• 12.5 Becton Dickinson and Company
• 12.6 Bio Rad Laboratories Inc.
• 12.7 Cell Signaling Technology Inc.
• 12.8 Danaher Corp.
• 12.9 GenScript Biotech Corp.
• 12.10 JSR Micro Inc.
• 12.11 Merck KGaA
• 12.12 OriGene Technologies Inc.
• 12.13 PerkinElmer Inc
• 12.14 Proteintech Group Inc.
• 12.15 Rockland Immunochemicals Inc.
• 12.16 Santa Cruz Biotechnology Inc.
• 12.17 Thermo Fisher Scientific Inc.

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• 13.3 Currency conversion rates for US$
• 13.4 Research methodology
• 13.5 List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits6: Executive Summary - Chart on Market Segmentation by Type
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global immunoprecipitation market 2018 - 2022 ($ million)
• Exhibits19: Historic Market Size - End-User Segment 2018 - 2022 ($ million)
• Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on End-user - Market share 2023-2028 (%)
• Exhibits31: Data Table on End-user - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by End-user
• Exhibits33: Data Table on Comparison by End-user
• Exhibits34: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
• Exhibits35: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
• Exhibits36: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Contract research organizations - Market size and forecast 2023-2028 ($ million)
• Exhibits39: Data Table on Contract research organizations - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Chart on Contract research organizations - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Contract research organizations - Year-over-year growth 2023-2028 (%)
• Exhibits42: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
• Exhibits43: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
• Exhibits44: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
• Exhibits45: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
• Exhibits46: Market opportunity by End-user ($ million)
• Exhibits47: Data Table on Market opportunity by End-user ($ million)
• Exhibits48: Chart on Type - Market share 2023-2028 (%)
• Exhibits49: Data Table on Type - Market share 2023-2028 (%)
• Exhibits50: Chart on Comparison by Type
• Exhibits51: Data Table on Comparison by Type
• Exhibits52: Chart on Chromatin immunoprecipitation - Market size and forecast 2023-2028 ($ million)
• Exhibits53: Data Table on Chromatin immunoprecipitation - Market size and forecast 2023-2028 ($ million)
• Exhibits54: Chart on Chromatin immunoprecipitation - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on Chromatin immunoprecipitation - Year-over-year growth 2023-2028 (%)
• Exhibits56: Chart on Individual protein immunoprecipitation - Market size and forecast 2023-2028 ($ million)
• Exhibits57: Data Table on Individual protein immunoprecipitation - Market size and forecast 2023-2028 ($ million)
• Exhibits58: Chart on Individual protein immunoprecipitation - Year-over-year growth 2023-2028 (%)
• Exhibits59: Data Table on Individual protein immunoprecipitation - Year-over-year growth 2023-2028 (%)
• Exhibits60: Chart on Co-immunoprecipitation - Market size and forecast 2023-2028 ($ million)
• Exhibits61: Data Table on Co-immunoprecipitation - Market size and forecast 2023-2028 ($ million)
• Exhibits62: Chart on Co-immunoprecipitation - Year-over-year growth 2023-2028 (%)
• Exhibits63: Data Table on Co-immunoprecipitation - Year-over-year growth 2023-2028 (%)
• Exhibits64: Chart on RNA immunoprecipitation - Market size and forecast 2023-2028 ($ million)
• Exhibits65: Data Table on RNA immunoprecipitation - Market size and forecast 2023-2028 ($ million)
• Exhibits66: Chart on RNA immunoprecipitation - Year-over-year growth 2023-2028 (%)
• Exhibits67: Data Table on RNA immunoprecipitation - Year-over-year growth 2023-2028 (%)
• Exhibits68: Market opportunity by Type ($ million)
• Exhibits69: Data Table on Market opportunity by Type ($ million)
• Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits73: Chart on Geographic comparison
• Exhibits74: Data Table on Geographic comparison
• Exhibits75: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits77: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits81: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits85: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits100: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits101: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits103: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits104: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits105: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits106: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits107: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits108: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits109: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits110: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits111: Market opportunity By Geographical Landscape ($ million)
• Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits113: Impact of drivers and challenges in 2023 and 2028
• Exhibits114: Overview on Criticality of inputs and Factors of differentiation
• Exhibits115: Overview on factors of disruption
• Exhibits116: Impact of key risks on business
• Exhibits117: Vendors covered
• Exhibits118: Matrix on vendor position and classification
• Exhibits119: Active Motif Inc. - Overview
• Exhibits120: Active Motif Inc. - Product / Service
• Exhibits121: Active Motif Inc. - Key offerings
• Exhibits122: Agilent Technologies Inc. - Overview
• Exhibits123: Agilent Technologies Inc. - Business segments
• Exhibits124: Agilent Technologies Inc. - Key news
• Exhibits125: Agilent Technologies Inc. - Key offerings
• Exhibits126: Agilent Technologies Inc. - Segment focus
• Exhibits127: Becton Dickinson and Company - Overview
• Exhibits128: Becton Dickinson and Company - Business segments
• Exhibits129: Becton Dickinson and Company - Key news
• Exhibits130: Becton Dickinson and Company - Key offerings
• Exhibits131: Becton Dickinson and Company - Segment focus
• Exhibits132: Bio Rad Laboratories Inc. - Overview
• Exhibits133: Bio Rad Laboratories Inc. - Business segments
• Exhibits134: Bio Rad Laboratories Inc. - Key news
• Exhibits135: Bio Rad Laboratories Inc. - Key offerings
• Exhibits136: Bio Rad Laboratories Inc. - Segment focus
• Exhibits137: Cell Signaling Technology Inc. - Overview
• Exhibits138: Cell Signaling Technology Inc. - Product / Service
• Exhibits139: Cell Signaling Technology Inc. - Key offerings
• Exhibits140: Danaher Corp. - Overview
• Exhibits141: Danaher Corp. - Business segments
• Exhibits142: Danaher Corp. - Key news
• Exhibits143: Danaher Corp. - Key offerings
• Exhibits144: Danaher Corp. - Segment focus
• Exhibits145: GenScript Biotech Corp. - Overview
• Exhibits146: GenScript Biotech Corp. - Business segments
• Exhibits147: GenScript Biotech Corp. - Key news
• Exhibits148: GenScript Biotech Corp. - Key offerings
• Exhibits149: GenScript Biotech Corp. - Segment focus
• Exhibits150: JSR Micro Inc. - Overview
• Exhibits151: JSR Micro Inc. - Product / Service
• Exhibits152: JSR Micro Inc. - Key offerings
• Exhibits153: Merck KGaA - Overview
• Exhibits154: Merck KGaA - Business segments
• Exhibits155: Merck KGaA - Key news
• Exhibits156: Merck KGaA - Key offerings
• Exhibits157: Merck KGaA - Segment focus
• Exhibits158: OriGene Technologies Inc. - Overview
• Exhibits159: OriGene Technologies Inc. - Product / Service
• Exhibits160: OriGene Technologies Inc. - Key offerings
• Exhibits161: PerkinElmer Inc - Overview
• Exhibits162: PerkinElmer Inc - Business segments
• Exhibits163: PerkinElmer Inc - Key news
• Exhibits164: PerkinElmer Inc - Key offerings
• Exhibits165: PerkinElmer Inc - Segment focus
• Exhibits166: Proteintech Group Inc. - Overview
• Exhibits167: Proteintech Group Inc. - Product / Service
• Exhibits168: Proteintech Group Inc. - Key offerings
• Exhibits169: Rockland Immunochemicals Inc. - Overview
• Exhibits170: Rockland Immunochemicals Inc. - Product / Service
• Exhibits171: Rockland Immunochemicals Inc. - Key offerings
• Exhibits172: Santa Cruz Biotechnology Inc. - Overview
• Exhibits173: Santa Cruz Biotechnology Inc. - Product / Service
• Exhibits174: Santa Cruz Biotechnology Inc. - Key offerings
• Exhibits175: Thermo Fisher Scientific Inc. - Overview
• Exhibits176: Thermo Fisher Scientific Inc. - Business segments
• Exhibits177: Thermo Fisher Scientific Inc. - Key news
• Exhibits178: Thermo Fisher Scientific Inc. - Key offerings
• Exhibits179: Thermo Fisher Scientific Inc. - Segment focus
• Exhibits180: Inclusions checklist
• Exhibits181: Exclusions checklist
• Exhibits182: Currency conversion rates for US$
• Exhibits183: Research methodology
• Exhibits184: Validation techniques employed for market sizing
• Exhibits185: Information sources
• Exhibits186: List of abbreviations